Peregrine Ventures

Peregrine Ventures

Or Yehuda, Tel Aviv Districtperegrinevc.com

Overview

Peregrine Ventures is a venture capital firm dedicated to supporting and advancing medical innovation through global strategic investments . The firm invests in early-stage technology companies, primarily in the healthcare and enterprise software sectors, with investments ranging from a few hundred thousand dollars to several million dollars . Peregrine is known for its hands-on approach to investing, working closely with portfolio companies to help them grow and achieve their business goals .

Year Founded

2001

Portfolio Companies

21

Investments

CompanyDateStageLead
KAHROct 2025Series BLead
Xerient PharmaFeb 2025SeedCo-investor
Lutris PharmaJan 2025Early FundingCo-investor
Nectin TherapeuticsMay 2024Series ACo-investor
VariantyxApr 2024VC RoundCo-investor

Key People

Eyal Lifschitz

Co-Founder General Managing Partner

Lior Shahory

General Partner

Daniel Cohen

Venture Partner

Marc Singer

Active Investor Consultant

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersOr Yehuda, Tel Aviv District
Year Founded2001

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.